Get the Stockscreener App
1.50
1.96%
-0.03
After Hours:
1.50
Pmv Pharmaceuticals Inc Stock (PMVP) Forecast
The Pmv Pharmaceuticals Inc (PMVP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.4914, representing a +399.42% increase from the current price of $1.50. The highest analyst price target is $14.51, and the lowest is $0.4724.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PMVP Price Target
Average 7.3602
(+390.68% Upside)
Is Pmv Pharmaceuticals Inc (PMVP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.58 | Neutral |
| STOCH(9,6) | 25.82 | Neutral |
| STOCHRSI(14) | 20.82 | Neutral |
| MACD(12,26) | -0.00892 | Sell |
| ADX(14) | 9.5256 | Neutral |
| William %R | -94.12 | Buy |
| CCI(14) | -181.49 | Sell |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.561
Sell
|
1.546
Sell
|
| MA20 |
1.545
Sell
|
1.5524
Sell
|
| MA50 |
1.5632
Sell
|
1.5891
Sell
|
| MA100 |
1.7036
Sell
|
1.7077
Sell
|
| MA200 |
1.855
Sell
|
2.3577
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PMVP could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on PMVP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.58 indicates that PMVP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 25.82 indicates that PMVP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 20.82 indicates that PMVP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 9.5256 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -181.49 indicates that PMVP is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term PMVP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pmv Pharmaceuticals Inc financial reports and earnings history, Pmv Pharmaceuticals Inc (PMVP) stock could reach $22.06 by 2030, $17.51 by 2040 and $130.62 by 2050. See the projected annual prices until 2050 of the Pmv Pharmaceuticals Inc stock below:
- Pmv Pharmaceuticals Inc (PMVP) is expected to reach an average price of $30.27 in 2035, with a high prediction of $29.61 and a low estimate of $29.50. This indicates an $1,918% rise from the last recorded price of $1.50.
- Pmv Pharmaceuticals Inc (PMVP) stock is projected to chart a bullish course in 2040, with an average price target of $16.56, representing an $1,004% surge from its current level. The forecast ranges from a conservative $16.58 to a sky-high $17.51.
- Our analysts predict Pmv Pharmaceuticals Inc (PMVP) to jump 8,803% by 2045, soaring from $136.32 to an average price of $133.54, potentially reaching $136.95. While $136.32 is the low estimate, the potential upside is significant.
- Pmv Pharmaceuticals Inc (PMVP) stock is expected to climb by 2050, reaching an average of $123.71, a $8,147% jump from its current level. However, a wide range of estimates exists, with high and low targets of $130.62 and $127.47, respectively, highlighting the market's uncertainty.
Pmv Pharmaceuticals Inc Stock (PMVP) Year by Year Forecast
Pmv Pharmaceuticals Inc Stock (PMVP) Price Forecast for 2024
Our forecast for PMVP stock price in 2024 now indicates an average price target of $16.35 with a high forecast of $32.48 and a low forecast of $0.2184. The average prediction reflects an increase of +990.02% from the last recorded price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2024 | $3.9174 | $0.4724 | $14.51 | +161.16% |
| November, 2024 | $5.9658 | $2.2287 | $6.9558 | +297.72% |
| December, 2024 | $8.0042 | $1.5629 | $8.5342 | +433.61% |
Pmv Pharmaceuticals Inc Stock (PMVP) Price Forecast for 2025
Pmv Pharmaceuticals Inc Stock (PMVP) is expected to reach an average price of $5.7045 in 2025, with a high prediction of $11.29 and a low estimate of $0.1197. This indicates an +280.30% rise from the last recorded price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $6.6197 | $2.6184 | $9.2813 | +341.31% |
| February, 2025 | $7.158 | $3.968 | $8.778 | +377.20% |
| March, 2025 | $8.3464 | $6.7722 | $11.29 | +456.43% |
| April, 2025 | $5.5819 | $0.7265 | $9.1985 | +272.13% |
| May, 2025 | $5.6403 | $1.6961 | $6.079 | +276.02% |
| June, 2025 | $0.4213 | $0.7613 | $5.9874 | -71.91% |
| July, 2025 | $1.4858 | $0.21 | $2.32 | -0.94% |
| August, 2025 | $0.8326 | $0.5245 | $2.1584 | -44.50% |
| September, 2025 | $5.2591 | $0.4097 | $3.9691 | +250.60% |
| October, 2025 | $5.9736 | $6.0236 | $5.6249 | +298.24% |
| November, 2025 | $1.1152 | $4.7152 | $4.9065 | -25.65% |
| December, 2025 | $1.2403 | $0.1197 | $3.9711 | -17.31% |
Pmv Pharmaceuticals Inc Stock (PMVP) Price Forecast for 2026
The predicted value for Pmv Pharmaceuticals Inc (PMVP) in 2026 is set at an average of $4.2621. Estimates vary from a peak of $7.5716 to a trough of $0.9526, indicating an +184.14% surge from the present price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.6513 | $0.9526 | $3.5313 | +343.42% |
| February, 2026 | $7.0629 | $6.7771 | $5.6442 | +370.86% |
| March, 2026 | $4.8046 | $7.4858 | $7.5716 | +220.30% |
| April, 2026 | $3.9191 | $2.8833 | $3.5575 | +161.27% |
| May, 2026 | $2.5907 | $2.8828 | $1.372 | +72.71% |
| June, 2026 | $2.7023 | $3.2794 | $2.5365 | +80.15% |
| July, 2026 | $3.8068 | $3.8052 | $3.0939 | +153.79% |
| August, 2026 | $3.7184 | $2.8955 | $2.6397 | +147.90% |
| September, 2026 | $4.2329 | $5.0142 | $4.13 | +182.20% |
| October, 2026 | $4.9746 | $4.9059 | $4.8146 | +231.64% |
| November, 2026 | $4.8162 | $5.1575 | $4.6633 | +221.08% |
| December, 2026 | $5.1907 | $4.8091 | $4.6291 | +246.05% |
Pmv Pharmaceuticals Inc Stock (PMVP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pmv Pharmaceuticals Inc (PMVP) is $3.6009, with a high forecast of $6.501 and a low forecast of $0.7007. This indicates an +140.06% increase from the last price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.3123 | $5.0886 | $5.8823 | +320.82% |
| February, 2027 | $6.7839 | $6.6952 | $6.501 | +352.26% |
| March, 2027 | $4.7884 | $5.1474 | $6.1268 | +219.23% |
| April, 2027 | $4.3701 | $4.4501 | $4.5342 | +191.34% |
| May, 2027 | $1.8217 | $3.3017 | $3.3659 | +21.44% |
| June, 2027 | $1.9262 | $2.1733 | $1.8904 | +28.41% |
| July, 2027 | $0.7178 | $0.8253 | $1.3409 | -52.15% |
| August, 2027 | $0.9794 | $0.7007 | $0.5165 | -34.71% |
| September, 2027 | $5.3839 | $1.4223 | $5.0839 | +258.93% |
| October, 2027 | $3.5255 | $4.0955 | $4.8318 | +135.04% |
| November, 2027 | $3.1272 | $3.1872 | $3.3264 | +108.48% |
| December, 2027 | $2.4517 | $2.0259 | $2.9101 | +63.45% |
Pmv Pharmaceuticals Inc Stock (PMVP) Price Forecast for 2028
In 2028, Pmv Pharmaceuticals Inc (PMVP) is projected to reach an average price of $15.04, with a high projection of $29.97 and a low estimate of $0.1018. This indicates an +902.36% rise from the last price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.3333 | $2.4033 | $2.4575 | +55.55% |
| February, 2028 | $1.6749 | $1.8549 | $2.1962 | +11.66% |
| March, 2028 | $1.0894 | $1.2094 | $1.3136 | -27.37% |
| April, 2028 | $0.451 | $0.601 | $0.8023 | -69.93% |
| May, 2028 | $29.66 | $0.1018 | $29.38 | +1,877% |
| June, 2028 | $28.32 | $29.80 | $29.97 | +1,788% |
| July, 2028 | $17.64 | $18.79 | $27.38 | +1,076% |
| August, 2028 | $16.43 | $11.54 | $13.60 | +995.14% |
| September, 2028 | $17.73 | $23.96 | $21.73 | +1,082% |
| October, 2028 | $15.43 | $20.41 | $20.25 | +928.90% |
| November, 2028 | $24.57 | $24.89 | $24.18 | +1,538% |
| December, 2028 | $23.80 | $23.45 | $21.43 | +1,486% |
Pmv Pharmaceuticals Inc Stock (PMVP) Price Forecast for 2029
The 2029 price forecast for Pmv Pharmaceuticals Inc Stock (PMVP) is $22.82 on average, with a high prediction of $27.39 and a low estimate of $18.25. This represents an +1,421% increase from the previous price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $20.33 | $21.11 | $20.33 | +1,256% |
| February, 2029 | $20.49 | $21.26 | $19.88 | +1,266% |
| March, 2029 | $15.47 | $18.86 | $17.69 | +931.42% |
| April, 2029 | $20.53 | $18.25 | $20.24 | +1,269% |
| May, 2029 | $19.61 | $20.77 | $19.66 | +1,208% |
| June, 2029 | $23.65 | $20.04 | $23.59 | +1,476% |
| July, 2029 | $21.94 | $23.74 | $22.80 | +1,363% |
| August, 2029 | $22.63 | $23.32 | $23.39 | +1,409% |
| September, 2029 | $26.81 | $22.09 | $25.42 | +1,687% |
| October, 2029 | $26.63 | $27.64 | $27.39 | +1,675% |
| November, 2029 | $25.72 | $25.92 | $26.08 | +1,615% |
| December, 2029 | $19.77 | $20.76 | $20.97 | +1,218% |
Pmv Pharmaceuticals Inc Stock (PMVP) Price Forecast for 2030
Pmv Pharmaceuticals Inc Stock (PMVP) is expected to reach an average price of $21.81 in 2030, with a high forecast of $25.95 and a low forecast of $17.67. This signifies an +1,354% surge from the last price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $24.63 | $20.12 | $22.06 | +1,542% |
| February, 2030 | $22.61 | $25.89 | $24.91 | +1,407% |
| March, 2030 | $26.19 | $26.14 | $25.95 | +1,646% |
| April, 2030 | $19.53 | $20.68 | $22.76 | +1,202% |
| May, 2030 | $17.22 | $19.94 | $18.72 | +1,048% |
| June, 2030 | $19.18 | $19.75 | $19.15 | +1,179% |
| July, 2030 | $19.78 | $19.74 | $19.05 | +1,219% |
| August, 2030 | $17.98 | $18.04 | $18.56 | +1,099% |
| September, 2030 | $18.87 | $19.06 | $18.63 | +1,158% |
| October, 2030 | $18.91 | $19.02 | $18.54 | +1,161% |
| November, 2030 | $18.52 | $18.68 | $18.49 | +1,134% |
| December, 2030 | $17.78 | $17.67 | $17.60 | +1,085% |
1.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):